JRJ
PTX

Jeffrey R. Jay’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Jeffrey R. Jay’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$1.07M Buy
+29,719
New +$1.11M 0.85% 25

Other funds holding PTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SC
Sageview Capital Greenwich, Connecticut $177M AUM 36.56% 1-Year Est. Return
FCAM
F&C Asset Management Edinburgh, Scotland, United Kingdom $7.92B AUM 24.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Jeffrey R. Jay's PTX Position: Q2 2013 in Review

Jeffrey R. Jay opened a new position in Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2013: 29,719 shares worth $1.07M. The stake represents 0.85% of the portfolio and ranks #25 among its holdings.

46 funds tracked by Wall St. Rank hold PTX as of Q2 2013.

  • Jeffrey R. Jay held 29,719 shares of Pernix Therapeutics Holdings, Inc. worth $1.07M as of Q2 2013.
  • Pernix Therapeutics Holdings, Inc. was a new Jeffrey R. Jay position in Q2 2013.
  • Pernix Therapeutics Holdings, Inc. made up 0.85% of Jeffrey R. Jay's portfolio in Q2 2013, its #25 holding.
  • 46 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2013.

Based on Jeffrey R. Jay's 13F filing for Q2 2013, filed 14 Aug 2013.